George Yaghmour

Assistant Professor of Clinical Medicine

Associate Director, Allogeneic Bone Marrow Transplant

Image of George Yaghmour
Is this your profile? Click to edit


George Yaghmour, MD has joined the Jane Anne Nohl Division of Hematology as Assistant Professor of Clinical Medicine. Dr. Yaghmour will be working specifically in the areas of Acute Leukemia and Allogeneic Stem Cell Transplantation. He graduated from University of Aleppo, Syria. He performed his residency training in Internal Medicine at Henry Ford Hospital/Wayne State University and then joined University of Tennessee Health Sciences Center/West Cancer Center in Memphis, TN for a clinical fellowship in Hematology and Medical Oncology. He is board certified in Internal Medicine, Hospital Medicine, Hematology and Medical Oncology.


  • Los Angeles Magazine: Top Doctors in Southern CA Rising Stars, 2017
  • Tennessee Oncology Practice Society: Outstanding Fellow Award, 2015
  • Asheville Hematologic Malignancies Symposium: Scholarship Award, 2015
  • VAMC Memphis: Star Team Award, 2014
  • Wayne State University, Henry Ford Hospital : Recognized and Ranked Top 5% Internal Medicine Residents, 2013
  • Henry Ford Hospital: Outstanding Patient Satisfaction/ Care, 2012
  • Aleppo University School of Medicine: Top 1% Graduate Award, 2008


  • Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center StudyClin Lymphoma Myeloma Leuk. 2024 03; 24(3):e59-e66. e2. . View in PubMed
  • Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease Front Oncol. 2024; 14:1329893. . View in PubMed
  • Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment Cell Mol Biol Lett. 2023 May 24; 28(1):45. . View in PubMed
  • Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia Blood Adv. 2023 04 11; 7(7):1279-1285. . View in PubMed
  • Unique challenges to diagnosing sweet syndrome following induction chemotherapy for relapsed Acute Myeloid Leukemia (AML): A case and brief-review Respir Med Case Rep. 2023; 46:101922. . View in PubMed
  • Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding Expert Opin Drug Metab Toxicol. 2023 Jan-Jun; 19(6):357-366. . View in PubMed
  • Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis Transpl Immunol. 2022 Dec 01; 101769. . View in PubMed
  • A novel approach to describing the pancreas and submandibular gland: Can they be classified as primary and secondary tissue organs? Acta Histochem. 2022 Aug; 124(6):151934.. View in PubMed
  • Hepatitic Variant of Graft-vs-Host Disease Am J Clin Pathol. 2022 06 07; 157(6):948-955. . View in PubMed
  • Unique Challenges to Diagnosing Human Herpesvirus-6 (HHV-6) Encephalitis Following Post-Hematopoietic Stem Cell Transplant: A Case and Brief Review Cell Transplant. 2022 Jan-Dec; 31:9636897221119734. . View in PubMed
  • Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia Am J Hematol. 2021 03 01; 96(3):E59-E63. . View in PubMed
  • Acute Respiratory Events and Dosimetry of Total Body Irradiation Patients Using In Vivo Lung Dose Monitoring and Custom Lung Block Adaptation Pract Radiat Oncol. 2020 Sep – Oct; 10(5):e397-e405. . View in PubMed
  • First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review World J Oncol. 2020 Jun; 11(3):112-115. . View in PubMed
  • The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab World J Oncol. 2020 Feb; 11(1):41-43. . View in PubMed
  • First reported case of BRAF V600E mutation in T-cell prolymphocytic leukaemia Br J Haematol. 2020 10; 191(2):e52-e55. . View in PubMed
  • Midostaurin-Related Interstitial Lung Injury in FLT3+ Acute Myeloid Leukemia Post-Allogeneic Transplant World J Oncol. 2019 Dec; 10(6):237-239. . View in PubMed
  • Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors World J Oncol. 2019 Dec; 10(6):226-230. . View in PubMed
  • Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant Br J Haematol. 2019 09; 186(5):e139-e141. . View in PubMed
  • Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia Cancer Med. 2019 06; 8(6):2832-2839. . View in PubMed
  • Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung Breast Cancer Res Treat. 2019 01; 173(1):243. . View in PubMed
  • A Case of Recurrent Pregnancy-Induced Adult Onset Familial Hemophagocytic Lymphohistiocytosis World J Oncol. 2018 Aug; 9(4):123-127. . View in PubMed
  • Impact of Provider Volume on Outcomes of Patients With Hodgkin Lymphoma World J Oncol. 2018 Apr; 9(2):46-49. . View in PubMed
  • Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia Leuk Res Rep. 2018; 9:18-20. . View in PubMed
  • The role of FLT3 inhibitors as maintenance therapy following hematopoietic stem cell transplant Leuk Res Rep. 2018; 10:26-36. . View in PubMed
  • Sweet’s syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine Ther Adv Hematol. 2017 Feb; 8(2):91-95. . View in PubMed
  • The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era – a surveillance, epidemiology, and end results database analysis Br J Haematol. 2017 11; 179(4):618-626. . View in PubMed
  • Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality Anticancer Res. 2017 02; 37(2):813-817. . View in PubMed
  • Genomic alterations in neuroendocrine cancers of the ovary J Ovarian Res. 2016 Aug 26; 9(1):52. . View in PubMed
  • Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors Anticancer Res. 2016 Aug; 36(8):4033-8. . View in PubMed
  • Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome Clin Lymphoma Myeloma Leuk. 2016 Apr; 16(4):230-6. . View in PubMed
  • Under-recognition of hemophagocytic syndrome in United States’ rural, non-teaching hospitals Leuk Lymphoma. 2016 12; 57(12):2911-2913. . View in PubMed
  • Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung Breast Cancer Res Treat. 2016 07; 158(1):195-202. . View in PubMed
  • How Center Volumes Affect Early Outcomes in Acute Myeloid Leukemia Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):646-54. . View in PubMed
  • Early mortality in acute myeloid leukemia Leuk Res. 2015 May; 39(5):505-9. . View in PubMed
  • Population-based Analysis of the Clinical Features of Primary Small Cell Carcinoma of the Ovary Anticancer Res. 2015 May; 35(5):3091-5. . View in PubMed
  • Ibrutinib has some activity in Richter’s syndrome Blood Cancer J. 2015 Jan 30; 5:e277. . View in PubMed
  • Drug-Induced Aseptic Meningitis Associated With Intrathecal Trastuzumab J Pharm Technol. 2014 Apr; 30(2):43-47. . View in PubMed
  • All that glitters is not gold: differential diagnosis of clover-leaf lymphocytes Int J Hematol. 2013 Jun; 97(6):679-80. . View in PubMed